Back

GLP-1 receptor agonists reduce infarct size relative to area at risk in myocardial infarction: a meta-analysis of randomized controlled trials

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Myocardial infarction and cardiogenic shock ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jasmin Kaur Bhullar

University of North Carolina Health Southeastern, Lumberton (United States of America)

4 More presentations in this session

Presentation thumbnail
Differential impact of mechanical circulatory support in STEMIversus NSTEMI cardiogenic shock
Assistant Professor M. Alvarez Villela (New York, US)
Abstract Slides Video
Presentation thumbnail
Early anxiety following acute myocardial infarction as a predictor of long-term psychological outcomes – Which screening method is most effective?
Ms C. Braun (Graz, AT)
Abstract Slides Video
Presentation thumbnail
Cardiogenic shock in patients with papillary muscle rupture post-acute myocardial infarction: a systematic review and meta-analysis
Doctor R. Filipescu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Late residual risk between 12 and 36 months after event-free survival following acute myocardial infarction
Professor D. Sim (Gwangju, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial infarction and cardiogenic shock

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists for anthracycline-associated cardiac outcomes: first meta-analytic evaluation in propensity-matched cohorts
30 August 2026
thumbnail
Congress Presentation
Pre-reperfusion dapagliflozin does not reduce infarct size in STt-elevation myocardial infarction: a randomized controlled trial
30 August 2026
thumbnail
Congress Presentation
Head to head comparison of ECPELLA versus venoarterial-ECMO in Myocardial Infarction associated cardiogenic shock: a meta-analysis
29 August 2026
thumbnail
Congress Presentation
Incremental cardiovascular benefit of GLP-1RA added to SGLT2i in type 2 diabetes: a target trial emulation in the US veterans health administration
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources